SCHEDULE 13G/A: Christopher Finn and Affiliates Report Passive Stake in Firefly Neuroscience, Inc.
Beneficial Ownership Report
Christopher Finn, Eadwacer Holdings, LLC, and Harleston Capital LLC have jointly filed an amended Schedule 13G, reporting a combined passive beneficial ownership of 4.1% in Firefly Neuroscience, Inc.'s common stock as of December 31, 2024.
Summary
- Christopher Finn, Eadwacer Holdings, LLC, and Harleston Capital LLC have jointly filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership of Common Stock in Firefly Neuroscience, Inc.
- As of December 31, 2024, Christopher Finn beneficially owns an aggregate of 349,223 shares, representing 4.1% of the class.
- Eadwacer Holdings, LLC beneficially owns 180,756 shares, representing 2.1% of the class.
- Harleston Capital LLC beneficially owns 168,467 shares, representing 2.0% of the class.
- All reporting persons have shared voting and shared dispositive power over their respective reported shares.
- Christopher Finn is the sole member of both Eadwacer Holdings, LLC and Harleston Capital LLC, and may be deemed to beneficially own the securities held by these entities.
- The filing indicates that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual report of beneficial ownership, providing no positive or negative sentiment regarding the company's performance or outlook. It is a neutral, compliance-driven filing.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of passive beneficial ownership and does not provide information related to broader industry trends or competitive analysis within the neuroscience or healthcare sectors. It merely updates the public record on a specific investor group's stake.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant passive ownership stakes, which can influence perceptions of investor confidence and liquidity.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement (beneficial ownership snapshot date). |
| 01/08/2025 | Date the Schedule 13G Amendment No. 1 was signed and filed. |
| 09/19/2024 | Date of the initial Schedule 13G filing by the Reporting Persons, referenced for the Joint Filing Agreement. |
Keywords
Firefly Neuroscience, Christopher Finn, Eadwacer Holdings, Harleston Capital, Schedule 13G, beneficial ownership, common stock, SEC filing, passive investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.